Diagnostics and Genomics: South Asia’s Growth Story

Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?

I bring overtwo decades of leadership experience in clinical diagnostics and life sciences,with a strong focus onmarket development, commercial transformation, and strategic partnerships across India and South Asia.

My expertise spansClinical Dx , Molecular diagnostics, genomics, and clinical workflows–Allergy , Autoimmunity, TDM ,Transplant Dx, where I have led high-growth portfolios, built large cross-functional teams, and driven double-digit growth while improving EBITDA.

I’ve worked extensively onscaling advanced technologies (NGS, PCR, clinical automation)in emerging markets—balancing innovation adoption withaffordability and access,which is critical in this region.

Q2. How are evolving healthcare priorities across South Asia shaping demand for advanced diagnostics and genetic testing?

Healthcare priorities in South Asia are shifting fromacute care to continuum-based care, driven by:

• Risingnon-communicable diseases (NCDs)
• Increasedhealth awareness and screening programs
• Government push foruniversal healthcare access
• Sample to report – POCT devices

This is accelerating demand for:

• Early diagnostics and screening (oncology, Reproductive health , infectious diseases)
• Genetic testing and precision medicine,especially in oncology and rare diseases
• Decentralized testing models…